Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users (Q44560334)

4 December 2017

title

Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users (English)

1 reference

Erratum to: Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users

4 December 2017

1 reference

corrigendum / erratum

0 references

author

James Stone

1

1 reference

4 December 2017

7

1 reference

4 December 2017

Hannah Furby

4

0 references

author name string

Fiona Pepper

2

1 reference

4 December 2017

Johnson Fam

3

1 reference

4 December 2017

Emer Hughes

5

1 reference

4 December 2017

Celia Morgan

6

1 reference

4 December 2017

publication date

22 November 2013

1 reference

4 December 2017

1 reference

4 December 2017

volume

231

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

2107-2116

1 reference

A case of psychosis associated with left thalamic lacunar infarcts

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Measurement of Glutamate and Glutamine in the Medial Prefrontal Cortex of Never-Treated Schizophrenic Patients and Healthy Controls by Proton Magnetic Resonance Spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Dysregulation of thalamic sensory "transmission" in schizophrenia: neurochemical vulnerability to hallucinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Proton magnetic resonance spectroscopy and illness stage in schizophrenia--a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Schizophrenia: a subcortical neurotransmitter imbalance syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Are treated alcoholics representative of the entire population with alcohol use disorders? A magnetic resonance study of brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

1 H MR Spectroscopy of the Brain: Absolute Quantification of Metabolites 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

In vivo and ex vivo evidence for ketamine‐induced hyperglutamatergic activity in the cerebral cortex of the rat: Potential relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Magnetic resonance imaging of brain in people at high risk of developing schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Reduced dorsal prefrontal gray matter after chronic ketamine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Starvation causes acute psychosis due to anterior thalamic infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Altered prefrontal dopaminergic function in chronic recreational ketamine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

The neuronal pathology of schizophrenia: molecules and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Attentional control and brain metabolite levels in methamphetamine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Thalamic neurochemical abnormalities in individuals with prodromal symptoms of schizophrenia - relationship to auditory event-related potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Glutamatergic mechanisms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

A systems model of altered consciousness: integrating natural and drug-induced psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Evidence for neuronal dysfunction in the anterior cingulate of patients with schizophrenia: a proton magnetic resonance spectroscopy study at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Lower glutamate levels in rostral anterior cingulate of chronic cocaine users - A (1)H-MRS study using TE-averaged PRESS at 3 T with an optimized quantification strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3354-8

Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia

21 January 2018

1 reference

12 December 2020

Proton magnetic resonance spectroscopy changes after antipsychotic treatment

1 reference

12 December 2020

Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results

1 reference

12 December 2020

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

12 December 2020

Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine users

1 reference

12 December 2020

Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function.

1 reference

12 December 2020

Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States

1 reference

12 December 2020

Schizophrenia-like psychosis associated with right lacunar thalamic infarct

1 reference

12 December 2020

Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects

1 reference

12 December 2020

Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

1 reference

12 December 2020

10.1007/S00213-013-3354-8

Identifiers

DOI

1 reference

4 December 2017

1 reference